Both in Medical Labs
GRAIL vs Fortrea Holdings
Over the past year GRAL returned +78.0% and FTRE returned +114.7%; their daily moves had a correlation of 0.25.
GRAL +78.0% FTRE +114.7%Growth of $1, one year, split-adjusted
| Metric | GRAL | FTRE |
|---|---|---|
| Price | $143.66 | $20.83 |
| Market cap | $6.42B | $2.01B |
| Today | +3.03% | −0.57% |
| 1 month | +4.6% | +0.2% |
| 6 months | +128.9% | +33.2% |
| Year to date | +67.8% | +20.8% |
| 1 year | — | +105.8% |
| Revenue growth (YoY) | +25.7% | −1.4% |
| Gross margin | −28.1% | 20.2% |
| Net margin | −246.7% | 0.1% |
| P/E (TTM) | — | — |
| Price / sales | 38.8× | 0.8× |
| Net cash | $861.6M | -$834.7M |
| Dividend yield | — | — |
| Volatility (60d) | 96.8% | 58.0% |
| Short % of float | 19.3% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).